A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2018
At a glance
- Drugs Dutogliptin (Primary) ; Filgrastim
- Indications Myocardial infarction
- Focus Adverse reactions
- Sponsors RECARDIO
- 06 Aug 2018 Planned initiation date (Estimated date of first patient enrollment) changed from 1 Jul 2018 to 1 Aug 2018.
- 30 Jul 2018 Status changed from not yet recruiting to recruiting.
- 18 Jul 2018 Planned initiation date changed from 1 Jun 2018 to 1 Jul 2018.